从生物监测到治疗考量：COVID-19向重症的演变 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

从生物监测到治疗考量：COVID-19向重症的演变 - Suppr | 超能文献

Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations.

作者信息

Carvelli Julien, Le Saux Audrey, Bourenne Jeremy, Gainnier Marc, Kaplanski Gilles

机构信息

Réanimation des Urgences, CHU Timone, AP-HM, Aix-Marseille Université, Marseille, France.

Marseille Immunopôle, CHU Timone, AP-HM, Marseille, France.

出版信息

Front Immunol. 2020 Dec 15;11:562038. doi: 10.3389/fimmu.2020.562038. eCollection 2020.

DOI:10.3389/fimmu.2020.562038

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7770161/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af1a/7770161/3922ce26878f/fimmu-11-562038-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af1a/7770161/3922ce26878f/fimmu-11-562038-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af1a/7770161/3922ce26878f/fimmu-11-562038-g001.jpg

相似文献

1

Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations.从生物监测到治疗考量：COVID-19向重症的演变

Front Immunol. 2020 Dec 15;11:562038. doi: 10.3389/fimmu.2020.562038. eCollection 2020.

2

The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?细胞因子风暴——对严重急性呼吸综合征冠状病毒2的一种适当的、过度反应的应答，还是错误的免疫途径？

Scand J Immunol. 2021 Mar;93(3):e12979. doi: 10.1111/sji.12979. Epub 2020 Oct 13.

3

Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.基本预测 COVID-19 患者细胞因子风暴的风险因素。

Front Immunol. 2021 Nov 10;12:745515. doi: 10.3389/fimmu.2021.745515. eCollection 2021.

4

An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.细胞因子风暴中心鉴定的相互关联细胞因子网络可预测 COVID-19 预后。

Cytokine. 2021 Feb;138:155365. doi: 10.1016/j.cyto.2020.155365. Epub 2020 Nov 9.

5

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?COVID-19 发病机制中的促炎细胞因子：出了什么问题？

Microb Pathog. 2021 Apr;153:104799. doi: 10.1016/j.micpath.2021.104799. Epub 2021 Feb 18.

6

Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.焦亡巨噬细胞刺激与SARS-CoV-2相关的细胞因子风暴。

Cell Mol Immunol. 2021 May;18(5):1305-1307. doi: 10.1038/s41423-021-00665-0. Epub 2021 Mar 19.

7

SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.SARS-CoV-2 引起的细胞因子反应与其他严重感染患者中导致细胞因子风暴的呼吸道病毒不同。

Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021.

8

Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.细胞因子风暴和I型干扰素反应在新冠病毒疾病发病机制中的关键决定因素

Clin Microbiol Rev. 2021 May 12;34(3). doi: 10.1128/CMR.00299-20. Print 2021 Jun 16.

9

Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。

Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.

10

Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases.用于预测 COVID-19 病例中细胞因子风暴相关疾病严重程度的多重免疫分析。

Methods Mol Biol. 2022;2511:245-256. doi: 10.1007/978-1-0716-2395-4_18.

本文引用的文献

1

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。

Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.

2

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.托珠单抗治疗重症 COVID-19 肺炎恶化：倾向评分分析。

J Clin Immunol. 2021 Feb;41(2):303-314. doi: 10.1007/s10875-020-00911-6. Epub 2020 Nov 14.

3

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.

用康替沙肽（一种补体、接触激活和激肽释放酶-激肽系统调节剂）治疗 COVID-19。

Front Immunol. 2020 Aug 14;11:2072. doi: 10.3389/fimmu.2020.02072. eCollection 2020.

4

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted.新型冠状病毒肺炎疾病阶段的临床试验：复杂且常被误解。

Lancet Glob Health. 2020 Oct;8(10):e1249-e1250. doi: 10.1016/S2214-109X(20)30365-X. Epub 2020 Aug 20.

5

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.COVID-19 患者使用激肽 B2 受体拮抗剂的相关结局。

JAMA Netw Open. 2020 Aug 3;3(8):e2017708. doi: 10.1001/jamanetworkopen.2020.17708.

6

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.COVID-19 炎症与 C5a-C5aR1 轴的激活有关。

Nature. 2020 Dec;588(7836):146-150. doi: 10.1038/s41586-020-2600-6. Epub 2020 Jul 29.

7

Longitudinal analyses reveal immunological misfiring in severe COVID-19.纵向分析揭示了重症 COVID-19 中的免疫失调。

Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27.

8

Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.COVID-19 并发严重炎症性呼吸衰竭患者的早期白细胞介素-1 受体阻断。

Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):18951-18953. doi: 10.1073/pnas.2009017117. Epub 2020 Jul 22.

9

Expression of the SARS-CoV-2 Receptor in the Human Airway Epithelium.SARS-CoV-2 受体在人呼吸道上皮细胞中的表达。

Am J Respir Crit Care Med. 2020 Jul 15;202(2):219-229. doi: 10.1164/rccm.202003-0541OC.

10

COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。

J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.